Login to Your Account



Biontech builds momentum with $270M series A round, brings in U.S. investors

By Cormac Sheridan
Staff Writer

Friday, January 5, 2018

DUBLIN – Biontech AG raised $270 million in a series A round that further adds to the sense of excitement and momentum building up around one of the global biotech industry's key innovators in immuno-oncology.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription